Open AccessNew Tricks and Old Dogs: Will the Addition of Venetoclax to Conventional Multidrug Chemotherapy Decrease Relapse Risk for Younger Adults With Newly Diagnosed AML?
Author(s) -
Grace Egan,
Sarah K. Tasian
Publication year - 2022
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v19.2.202224
Subject(s) - venetoclax , chemotherapy , medicine , oncology , pediatrics , leukemia , chronic lymphocytic leukemia